Hi futurenow - As I read the Medigard - Announcement to Shareholders 14/05/15 it states the current low production will be distributed for clinical evaluations and study etc - in other words could still not pass, and certainly no sales. That is, unless I have missed something since 14/05, why I can't understand your comment about - No further delays as problems overcome and sales being made to Sol-M customers.